TABLE 3.
The incidences of main adverse effects and of TXLC Plus CTs vs. CTs
| Adverse effects | TXLC plus CTs | Studies | CTs | Studies | ||
|---|---|---|---|---|---|---|
| Adverse effect (n) | Trials(n) | Adverse effect (n) | Trials(n) | |||
| Gastrointestinal symptoms such as bloating, belching, nausea, loss of appetite, acid reflux, and dull pain | 41 | 11 | Cui (2008), Du (2016), Liu and An (2016), Ma et al. (2011), Tian and Xu (2005), Wang and Li (2007), Wang et al. (2009), Wu (2011), Wu S. J. et al. (2006), Xin et al. (2008), Zhou (2013) | 5 | 1 | Liu and An (2016) |
| Hypotension | 1 | 1 | Yang et al. (2019) | 2 | 1 | Yang et al. (2019) |
| Bleeding gums | 2 | 2 | Ma et al. (2011), Wang and Li (2007) | 0 | 0 | no |
| Bradycardia | 1 | 1 | Yang et al. (2019) | 1 | 1 | Yang et al. (2019) |
Note: TXLC, Tongxinluo capsule; CTs, conventional treatments.